-
Original Article
-
- Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations
-
Anouk Lindley1
, Gerald Prager2, Michael Bitzer3, Timothy C. Burn1, Christine F. Lihou1, Elisabeth Croft1
-
1Incyte Corporation, Wilmington, USA
2Medical University of Vienna, Department of Internal Medicine I, Comprehensive Cancer Center Vienna, Vienna, Austria
3Department of Internal Medicine I, Eberhard-Karls University, Tübingen, Germany
- Corresponding author: Elisabeth Croft ,Tel: 1-302-498-5285, Email: erichards@incyte.com
- Received: November 8, 2023; Accepted: February 6, 2024.
- Abstract
-
Fatal error: Call to undefined function abstract_title() in /home/virtual/e-crt/journal/m/journal/include.m_db.php on line 196
